Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization-Reference-Cited by-同舟云学术

Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization

Published:2014-01-21 Issue:3 Volume:129 Page:293-303
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Wallentin Lars¹,Lindholm Daniel¹,Siegbahn Agneta¹,Wernroth Lisa¹,Becker Richard C.¹,Cannon Christopher P.¹,Cornel Jan H.¹,Himmelmann Anders¹,Giannitsis Evangelos¹,Harrington Robert A.¹,Held Claes¹,Husted Steen¹,Katus Hugo A.¹,Mahaffey Kenneth W.¹,Steg Ph. Gabriel¹,Storey Robert F.¹,James Stefan K.¹

Affiliation:

1. From the Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (L.W., D.L., L.W., C.H., S.K.J.); Department of Medical Sciences, Clinical Chemistry and Uppsala Clinical Research Center Uppsala University, Uppsala, Sweden (A.S.); Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, Academic Health Center, Cincinnati, OH (R.C.B.); Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); TIMI...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference34 articles.

1. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).;Authors/Task Force Members;Eur Heart J,2011

2. 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.;Wright RS;Circulation,2011

3. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

4. Comparative trends in guidelines adherence among patients with non–ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative

5. Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth differentiation factor-15 as a biomarker of coronary microvascular dysfunction in ST-segment elevation myocardial infarction;Heliyon;2024-08

2. Clinical Follow-Up of Patients after Coronary Artery Bypass Grafting;Cardiology and Cardiovascular Medicine;2024-06-19

3. Evaluation of the efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina: A randomized, double-blind, placebo-controlled, multi-center clinical trial;Journal of Ethnopharmacology;2024-01

4. Unstable angina in the context of high-sensitive troponins: Still a marker of high risk? A comparison of outcomes with adjudicated type 1 myocardial infarction;International Journal of Cardiology;2023-11

5. CURRENT VIEWS ON THE ROLE OF GROWTH DIFFERENTIATION FACTOR 15 IN THE GENESIS, COURSE AND OUTCOME OF CARDIOVASCULAR PATHOLOGY;Complex Issues of Cardiovascular Diseases;2023-09-25